Epstein Files Search

EFTA01388329Dataset 10

1p251w

…the calendar month immediately following the Effective Date and (ii) for each subsequent Calculation Period, the period from, and including, the last day of the preceding Calculation Period to, but excluding, the first day of the calendar month immediately following such last day. "Payment Date" means the first TARGET Settlement Day following a Reset Date. -Termination Date" means the final Payment Date. I3 CONFIDENTIAL - PURSUANT TO FED. R. CRIM. P. 6(e) DB-SDNY-0091818 CONFIDENTIAL SDNY GM_00238002 EFTA01388329

https://www.justice.gov/epstein/files/DataSet%2010/EFTA01388329.pdf

EFTA01366696Dataset 10

2015-07-201p459w

…Crass B1 units and Class B units. pro rata dell each holder receives a total d SO 3163 per Lest for that quarter. or the 'First Target Distiituton• (115 0%d the Minimum Quarterly Orstntaban). • seccncl 85 0% lo all holders d Class A (-nits, Class 81 urts art Class B units pro rate, and 15 0% to ire holders Cl the ORA (AN each holler of Class A vat& Class B1 knits and Class B units recedes a total…

https://www.justice.gov/epstein/files/DataSet%2010/EFTA01366696.pdf

EFTA00810576Dataset 9

2018-04-0526p9,385w

…patients Veru is developing Solifenacin DRG, as a novel slow release granule formulation of solifenacin succinate that can be taken as an oral suspension in dysphagic patients with OAB. This will increase compliance in these patients who will be the first target population. Although solifenacin is one of the lowest cost drugs to treat OAB in US with an average cost of $6.8k for one successful treatment, solifenacin has a $1.1B market worldwide. We expect that Solifenacin-DRG…

https://www.justice.gov/epstein/files/DataSet%209/EFTA00810576.pdf

EFTA01195155Dataset 9

2014-04-1333p14,550w

Subject: Greg Brown's Weekend Reading and Other Things.... 04/13/2014

From: Gregory BrownTo: undisclosed-recipients:;

…time an executive wines and dines a hot date on the corporate dime, the average taxpayer helps foot the bill. So let's get real. To stem abuses, the first target shouldn't be those avaricious infants in nutrition programs but tycoons in their subsidized Gulfstreams. However imperfectly, subsidies for the poor do actually reduce hunger, ease suffering and create opportunity, while subsidies for the rich result in more private jets and yachts. Would we rather subsidize opportunity or yachts…

https://www.justice.gov/epstein/files/DataSet%209/EFTA01195155.pdf

EFTA01100261Dataset 9

2016-02-2939p20,086w

Editas Medicine] February 29. 2016 Morgan Stanley MORGAN STANLEY RESEARCH MORGAN STANLEY & CO. LLC February 29, 2016 Matthew Harrison Editas Medicine David N Lebowitz, MPH. CFA '1212 761-8055 Starting A Gene Editing Revolution '1212 761-0324 Cyrus Amoozegar, M.D., Ph.D. .1212 761-6009 Industry View Stock Rating Price Target In-Line Equal-weight $28.00 Editas Medicine ( EDIT.O, EDIT US ) We initiate at EW with a $28 PT; Despite our LT optimism for the Biotechnology / United…

https://www.justice.gov/epstein/files/DataSet%209/EFTA01100261.pdf

EFTA00506070Dataset 9

2013-08-2236p3,940w

…Day 60 Milestones • 7-month enrollment period • 5 month subject participation period • 1-Month from Last patient out to database lock • 1-Month from database lock to topline data Highly cost-efficient clinical trial plan • Example: Australia has 615% rebate/tax credit • No competing shingles trials actively recruiting 17 17 EFTA00506086 2013-08-22 Shingles is the first target market for EPB-348, growing to more than $1 Billion Market Potential (in Smillions)' • Sales volume in the major pharmaceutical markets…

https://www.justice.gov/epstein/files/DataSet%209/EFTA00506070.pdf